Variations In Mortality Risk Among COPD Patients In Clinical Trials: Data From The Uplift Study

被引:0
|
作者
Burgel, P-R [1 ]
Paillasseur, J-L [2 ]
Dusser, D. [1 ]
Roche, N. [1 ]
Liu, D. [3 ]
Liu, Y. [3 ]
Furtwaengler, A. [3 ]
Metzdorf, N. [3 ]
Decramer, M. [4 ]
机构
[1] Univ Paris 05, Pulm Unit, Paris, France
[2] Clindatafirst, Clamart, France
[3] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany
[4] Katholieke Univ Leuven, Leuven, Belgium
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A5558
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Mortality in a cohort of COPD patients according to their clinical phenotype
    Lopez, Laura Castellanos
    Bordonaba, Guillermo Ansede
    Gonzalez, Patricia Perez
    Castillo, Elena Garcia
    Perez, Tamara Alonso
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [32] Phenotypes, treatable traits, GOLD groups and grades - how they predict mortality risk in COPD patients? (data from the Czech Multicenter Research Database of COPD)
    Brat, Kristian
    Koblizek, Vladimir
    Svoboda, Michal
    Plutinsky, Marek
    Zatloukal, Jaromir
    Volakova, Eva
    Novotna, Barbora
    Popelkova, Patrice
    Dvorak, Tomas
    Kudela, Ondrej
    Kopecky, Michal
    Musilova, Pavlina
    Kocova, Eva
    Vanik, Petr
    Heribanova, Lucie
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [33] Data Collection Issues With Mortality Risk of Inhaled Corticosteroids in COPD
    Oba, Yuji
    CHEST, 2023, 163 (05) : E247 - E247
  • [34] Ten Years' Mortality Data Of Patients With Chronic Obstructive Pulmonary Disease From The Hokkaido COPD Cohort Study
    Makita, H.
    Suzuki, M.
    Konno, S.
    Shimizu, K.
    Ito, Y. M.
    Nishimura, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [35] Increased mortality among patients with rheumatoid arthritis and COPD: A population-based study
    Hyldgaard, Charlotte
    Bendstrup, Elisabeth
    Pedersen, Alma Becic
    Ulrichsen, Sinna Pilgaard
    Lokke, Anders
    Hilberg, Ole
    Ellingsen, Torkell
    RESPIRATORY MEDICINE, 2018, 140 : 101 - 107
  • [36] Defining a COPD composite safety endpoint for demonstrating efficacy in clinical trials: results from the randomized, placebo-controlled UPLIFT® trial
    Celli, Bartolome R.
    Decramer, Marc
    Liu, Dacheng
    Metzdorf, Norbert
    Asijee, Guus M.
    Tashkin, Donald P.
    RESPIRATORY RESEARCH, 2016, 17
  • [37] Extended therapy with ipratropium is associated with improved lung function in patients with COPD - A retrospective analysis of data from seven clinical trials
    Rennard, SI
    Serby, CW
    Ghafouri, M
    Johnson, PA
    Friedman, M
    CHEST, 1996, 110 (01) : 62 - 70
  • [38] Safety Of Inhaled Glycopyrrolate In Patients With Moderate-To-Severe COPD: Subgroup Analysis From The Pooled Data Of Four Clinical Trials
    D'Andrea, P.
    LaForce, C.
    Pedinoff, A.
    Miller, S.
    Yadao, A.
    Uddin, A.
    Franke-Bray, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [39] Cardiac safety of tiotropium in patients with COPD: a combined analysis of Holter-ECG data from four randomised clinical trials
    Hohlfeld, J. M.
    Furtwaengler, A.
    Koenen-Bergmann, M.
    Wallenstein, G.
    Walter, B.
    Bateman, E. D.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2015, 69 (01) : 72 - 80
  • [40] Respiratory parameters predict mortality in COPD patients - data from the Czech multicentre research database of severe COPD
    Brat, Kristian
    Koblizek, Vladimir
    Plutinsky, Marek
    Zatloukal, Jaromir
    Popelkova, Patrice
    Dvorak, Tomas
    Safranek, Petr
    Sobotik, Ondrej
    Vlachova, Alena
    Vanik, Petr
    Liptakova, Zuzana
    Heribanova, Lucie
    Snelerova, Blanka
    Musilova, Pavlina
    Majerciakova, Maria
    Vencalek, Tomas
    Kocova, Eva
    Novotna, Barbora
    Kopecky, Michal
    Kudela, Ondrej
    Neumannova, Katerina
    Volakova, Eva
    Hejduk, Karel
    Svancara, Jan
    Jarkovsky, Jiri
    Svoboda, Michal
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50